Lexaria Bioscience Corp. Quarterly Common Stock, Shares, Outstanding from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Lexaria Bioscience Corp. quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2010 to Q3 2024.
  • Lexaria Bioscience Corp. Common Stock, Shares, Outstanding for the quarter ending August 31, 2024 was 15.8M shares, a 95.4% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 15.8M +7.72M +95.4% Aug 31, 2024 10-K 2024-11-26
Q2 2024 15.8M +7.72M +95.4% May 31, 2024 10-Q 2024-07-12
Q1 2024 12.4M +6.44M +108% Feb 29, 2024 10-Q 2024-04-09
Q4 2023 10.3M +4.36M +73.3% Nov 30, 2023 10-Q 2024-01-12
Q3 2023 8.09M +2.14M +36% Aug 31, 2023 10-K 2024-11-26
Q2 2023 8.09M +2.14M +36% May 31, 2023 10-Q 2023-07-14
Q1 2023 5.95M 0 0% Feb 28, 2023 10-Q 2023-04-14
Q4 2022 5.95M +224K +3.92% Nov 30, 2022 10-Q/A 2023-01-18
Q3 2022 5.95M +224K +3.92% Aug 31, 2022 10-K 2023-11-20
Q2 2022 5.95M +847K +16.6% May 31, 2022 10-Q 2022-07-14
Q1 2022 5.95M +847K +16.6% Feb 28, 2022 10-Q 2022-04-11
Q4 2021 5.73M +2.73M +90.8% Nov 30, 2021 10-Q 2022-01-14
Q3 2021 5.73M +2.73M +90.8% Aug 31, 2021 10-K 2022-11-28
Q2 2021 5.1M -84.5M -94.3% May 31, 2021 10-Q 2021-07-15
Q1 2021 5.1M -75.6M -93.7% Feb 28, 2021 10-Q 2021-04-14
Q4 2020 3M -77.6M -96.3% Nov 30, 2020 10-Q 2021-01-14
Q3 2020 3M -75.8M -96.2% Aug 31, 2020 10-K 2021-11-29
Q2 2020 89.6M +11.1M +14.2% May 31, 2020 10-Q 2020-06-30
Q1 2020 80.7M +2.72M +3.49% Feb 29, 2020 10-Q 2020-04-03
Q4 2019 80.6M +3.49M +4.53% Nov 30, 2019 10-Q 2020-01-09
Q3 2019 78.8M +3.25M +4.31% Aug 31, 2019 10-K 2020-10-15
Q2 2019 78.4M +6.04M +8.34% May 31, 2019 10-Q 2019-07-08
Q1 2019 78M +6.9M +9.71% Feb 28, 2019 10-Q 2019-04-15
Q4 2018 77.1M +7.69M +11.1% Nov 30, 2018 10-Q 2019-01-11
Q3 2018 75.5M +7.56M +11.1% Aug 31, 2018 10-K 2019-11-14
Q2 2018 72.4M +5.85M +8.78% May 31, 2018 10-Q 2018-07-13
Q1 2018 71.1M +14.8M +26.3% Feb 28, 2018 10-Q 2018-04-12
Q4 2017 69.4M +14.4M +26.2% Nov 30, 2017 10-Q 2018-01-12
Q3 2017 68M +16.7M +32.5% Aug 31, 2017 10-K 2018-11-14
Q2 2017 66.6M +21M +46.2% May 31, 2017 10-Q 2017-07-14
Q1 2017 56.3M +11.7M +26.4% Feb 28, 2017 10-Q 2017-04-14
Q4 2016 55M +15.1M +37.7% Nov 30, 2016 10-Q 2017-01-13
Q3 2016 51.3M +7.45M +17% Aug 31, 2016 10-K 2017-11-27
Q2 2016 45.5M +5.83M +14.7% May 31, 2016 10-Q 2016-07-13
Q1 2016 44.6M +9.87M +28.5% Feb 29, 2016 10-Q 2016-04-13
Q4 2015 40M +5.51M +16% Nov 30, 2015 10-Q 2016-01-08
Q3 2015 43.8M +9.59M +28% Aug 31, 2015 10-K 2016-11-29
Q2 2015 39.7M +6.86M +20.9% May 31, 2015 10-Q 2015-07-14
Q1 2015 34.7M +2.84M +8.93% Feb 28, 2015 10-Q 2015-04-14
Q4 2014 34.4M +17.5M +103% Nov 30, 2014 10-Q 2015-01-14
Q3 2014 34.2M +17.8M +108% Aug 31, 2014 10-K 2015-11-27
Q2 2014 32.8M +16.4M +99.8% Jul 31, 2014 10-Q/A 2014-11-14
Q1 2014 31.8M +15.4M +93.8% Apr 30, 2014 10-Q 2014-06-12
Q4 2013 16.9M +500K +3.04% Jan 31, 2014 10-Q 2014-03-12
Q3 2013 16.4M 0 0% Oct 31, 2013 10-KT 2014-12-09
Q2 2013 16.4M 0 0% Jul 31, 2013 10-Q 2013-09-10
Q1 2013 16.4M 0 0% Apr 30, 2013 10-Q 2013-06-12
Q4 2012 16.4M 0 0% Jan 31, 2013 10-Q 2013-03-13
Q3 2012 16.4M 0 0% Oct 31, 2012 10-K 2014-01-24
Q2 2012 16.4M +800K +5.12% Jul 31, 2012 10-Q 2012-09-12
Q1 2012 16.4M Apr 30, 2012 10-Q 2012-06-07
Q4 2011 16.4M Jan 31, 2012 10-Q 2012-03-13
Q3 2011 16.4M +3.51M +27.1% Oct 31, 2011 10-K 2013-01-29
Q2 2011 15.6M Jul 31, 2011 10-Q 2011-09-14
Q3 2010 12.9M Oct 31, 2010 10-K 2012-01-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.